FIELD: medicine, virology, pharmacology, pharmacy. SUBSTANCE: invention relates to novel interferon effectors with respect to viruses inducing human herpes and papilloma. The base active component is a mixture of interferon aminocaproic acid or a mixture of interferon, aminocaproic acid and riboflavin and these mixtures are used for development of three novel medicinal forms: ointment, gel, suppository. Invention provides preparing the composition showing the prolonged effect interferon also with prolonged initial activity. An active component is effective with respect to oncogenic viruses of papillomas HPV-16 and HPV-18 being at their combined infection of cells with genital herpes virus HSV-2. This provides its use as a prophylactic agent preventing neoplastic transformation of uterine cervix epithelial cells. EFFECT: enhanced effectiveness of composition, valuable anticancer properties. 5 cl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PRECANCER UTERINE CERVIX DISEASE CASES | 2004 |
|
RU2271804C1 |
| 3,3'-DIINDOLYLMETHANE (METINDOL)-BASE VAGINAL SUPPOSITORY | 2006 |
|
RU2318510C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT OF DYSPLASTIC PROCESSES OF CERVIX | 2008 |
|
RU2395281C2 |
| PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF UTERUS CERVIX DYSPLASIA AND CANCER AND LARYNX PAPILLOMATOSIS AND METHOD OF PROPHYLAXIS AND TREATMENT OF SAID SICKNESSES BASED ON THEREOF | 2001 |
|
RU2196568C1 |
| MUCOSAL VACCINE FOR IMMUNE THERAPY OF DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES, AND RELATED THERAPY (VERSIONS) | 2008 |
|
RU2377305C1 |
| MEDICINAL AGENT FOR TREATMENT OF VIRAL CUTANEOUS AND TUMOR DISEASES | 2002 |
|
RU2302861C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING LOCAL MANIFESTATIONS OF HERPEX SIMPLEX INFECTIONS AND FOR PREVENTING INFLUENZA AND ACUTE RESPIRATORY VIRAL INFECTIONS | 2013 |
|
RU2514103C1 |
| AGENT FOR EXTERNAL USE WITH ANTIVIRAL ACTION | 2021 |
|
RU2819719C2 |
| ANTIVIRAL GEL AS GEL BASED ON HUMAN LEUKOCYTE INTERFERON | 2005 |
|
RU2302881C2 |
| METHOD OF COMBINED THERAPY OF CERVICAL DYSPLASIA ASSOCIATED WITH HUMAN PAPILLOMA VIRUSES | 2019 |
|
RU2701525C1 |
